澳门永利官网网址55402|NO.1

Pipeline

Shenogen Pharmaceutical is committed to the R&D and production of oncology drugs and immune-inflammatory drugs, integrating innovative strength in one, such as new technologies, new targets, new products and independent IPs. The Group has diverse pipelines, and many have entered the late stage clinical trial.


Baidu
sogou